Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Kevin T. Conroy | President and CEO, Director | $65M | -$1.82M | -2.72% | Nov 13, 2024 |
Sarah Condella | EVP, Human Resources | $5.38M | -$743K | -12.1% | Apr 30, 2024 |
Everett Cunningham | Chief Commercial Officer | $3.81M | -$439K | -10.4% | Apr 30, 2024 |
Katherine S. Zanotti | Director | $3.62M | Jun 13, 2024 | ||
James Edward Doyle | Director | $2.88M | -$115K | -3.84% | Jun 13, 2024 |
D. Scott Coward | Director | $2.6M | -$172K | -6.2% | Jun 13, 2024 |
Jacob A. Orville | EVP, GM, Screening | $2.22M | -$427K | -16.1% | Aug 5, 2024 |
Brian Baranick | EVP, GM, Precision Oncology | $2.12M | -$584K | -21.6% | Oct 8, 2024 |
Jeffrey Thomas Elliott | Chief Financial Officer | $1.75M | -$594K | -25.4% | Apr 30, 2024 |
Pierre Jacquet | Director | $1.73M | Jun 8, 2023 | ||
Kathleen Sebelius | Director | $1.68M | Jun 13, 2024 | ||
Daniel J. Levangie | Director | $1.48M | -$288K | -16.2% | Jun 13, 2024 |
Freda Lewis-Hall | Director | $1.45M | Jun 8, 2023 | ||
Paul J. Clancy | Director | $1.06M | Jun 13, 2024 | ||
James Herriott | SVP, General Counsel & Sec | $1M | -$166K | -14.2% | Apr 30, 2024 |
Shacey Petrovic | Director | $842K | Jun 13, 2024 | ||
Timothy J. Scannell | Director | $419K | Oct 31, 2023 | ||
Thomas D. Carey | Director | $389K | Jun 2, 2021 | ||
Kimberly J. Popovits | Director | $328K | Jan 2, 2025 | ||
Michael J. Barber | Director | $305K | Jun 13, 2024 | ||
Aaron Bloomer | EVP, Chief Financial Officer | May 15, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|